124 related articles for article (PubMed ID: 34461087)
21. Interaction of cryptophycin 1 with tubulin and microtubules.
Kerksiek K; Mejillano MR; Schwartz RE; Georg GI; Himes RH
FEBS Lett; 1995 Dec; 377(1):59-61. PubMed ID: 8543019
[TBL] [Abstract][Full Text] [Related]
22. Cryo-EM reveals the structural basis of microtubule depolymerization by kinesin-13s.
Benoit MPMH; Asenjo AB; Sosa H
Nat Commun; 2018 Apr; 9(1):1662. PubMed ID: 29695795
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of macromolecular synthesis by cryptophycin-52.
Subramanian B; Nakeff A; Media JE; Wiegand RA; Valeriote FA
Anticancer Drugs; 2002 Nov; 13(10):1061-8. PubMed ID: 12439340
[TBL] [Abstract][Full Text] [Related]
24. High-resolution microtubule structures reveal the structural transitions in αβ-tubulin upon GTP hydrolysis.
Alushin GM; Lander GC; Kellogg EH; Zhang R; Baker D; Nogales E
Cell; 2014 May; 157(5):1117-29. PubMed ID: 24855948
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates.
Borbély A; Thoreau F; Figueras E; Kadri M; Coll JL; Boturyn D; Sewald N
Chemistry; 2020 Feb; 26(12):2602-2605. PubMed ID: 31943410
[TBL] [Abstract][Full Text] [Related]
26. Preclinical anticancer activity of cryptophycin-8.
Corbett TH; Valeriote FA; Demchik L; Polin L; Panchapor C; Pugh S; White K; Knight J; Jones J; Jones L; LoRusso P; Foster B; Wiegand RA; Lisow L; Golakoti T; Heltzel CE; Ogino J; Patterson GM; Moore RE
J Exp Ther Oncol; 1996 Mar; 1(2):95-108. PubMed ID: 9414393
[TBL] [Abstract][Full Text] [Related]
27. Cryo-EM structure of VASH1-SVBP bound to microtubules.
Li F; Li Y; Ye X; Gao H; Shi Z; Luo X; Rice LM; Yu H
Elife; 2020 Aug; 9():. PubMed ID: 32773040
[TBL] [Abstract][Full Text] [Related]
28. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1.
Bai R; Durso NA; Sackett DL; Hamel E
Biochemistry; 1999 Oct; 38(43):14302-10. PubMed ID: 10572005
[TBL] [Abstract][Full Text] [Related]
29. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
Shih C; Teicher BA
Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
[TBL] [Abstract][Full Text] [Related]
30. Conformational changes in tubulin in GMPCPP and GDP-taxol microtubules observed by cryoelectron microscopy.
Yajima H; Ogura T; Nitta R; Okada Y; Sato C; Hirokawa N
J Cell Biol; 2012 Aug; 198(3):315-22. PubMed ID: 22851320
[TBL] [Abstract][Full Text] [Related]
31. Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography.
Cruz-Monserrate Z; Mullaney JT; Harran PG; Pettit GR; Hamel E
Eur J Biochem; 2003 Sep; 270(18):3822-8. PubMed ID: 12950266
[TBL] [Abstract][Full Text] [Related]
32. Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 days.
Stevenson JP; Sun W; Gallagher M; Johnson R; Vaughn D; Schuchter L; Algazy K; Hahn S; Enas N; Ellis D; Thornton D; O'Dwyer PJ
Clin Cancer Res; 2002 Aug; 8(8):2524-9. PubMed ID: 12171879
[TBL] [Abstract][Full Text] [Related]
33. Hallmarks of molecular action of microtubule stabilizing agents: effects of epothilone B, ixabepilone, peloruside A, and laulimalide on microtubule conformation.
Khrapunovich-Baine M; Menon V; Yang CP; Northcote PT; Miller JH; Angeletti RH; Fiser A; Horwitz SB; Xiao H
J Biol Chem; 2011 Apr; 286(13):11765-78. PubMed ID: 21245138
[TBL] [Abstract][Full Text] [Related]
34. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
Eissler S; Bogner T; Nahrwold M; Sewald N
Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
[TBL] [Abstract][Full Text] [Related]
35. Berberine Induces Toxicity in HeLa Cells through Perturbation of Microtubule Polymerization by Binding to Tubulin at a Unique Site.
Raghav D; Ashraf SM; Mohan L; Rathinasamy K
Biochemistry; 2017 May; 56(20):2594-2611. PubMed ID: 28459539
[TBL] [Abstract][Full Text] [Related]
36. Cellular uptake of a novel cytotoxic agent, cryptophycin-52, by human THP-1 leukemia cells and H-125 lung tumor cells.
Chen BD; Nakeff A; Valeriote F
Int J Cancer; 1998 Sep; 77(6):869-73. PubMed ID: 9714056
[TBL] [Abstract][Full Text] [Related]
37. Caulerpenyne binding to tubulin: structural modifications by a non conventional pharmacological agent.
Bourdron J; Barbier P; Allegro D; Villard C; Lafitte D; Commeiras L; Parrain JL; Peyrot V
Med Chem; 2009 Mar; 5(2):182-90. PubMed ID: 19275717
[TBL] [Abstract][Full Text] [Related]
38. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
[TBL] [Abstract][Full Text] [Related]
39. A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs.
Prota AE; Bargsten K; Diaz JF; Marsh M; Cuevas C; Liniger M; Neuhaus C; Andreu JM; Altmann KH; Steinmetz MO
Proc Natl Acad Sci U S A; 2014 Sep; 111(38):13817-21. PubMed ID: 25114240
[TBL] [Abstract][Full Text] [Related]
40. Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule.
Sessa C; Weigang-Köhler K; Pagani O; Greim G; Mora O; De Pas T; Burgess M; Weimer I; Johnson R
Eur J Cancer; 2002 Dec; 38(18):2388-96. PubMed ID: 12460783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
